Can acupuncture stop an asthma attack? new study investigates
NCT ID NCT07632352
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding hand acupuncture to standard medicine can quickly improve breathing during an asthma flare-up. Researchers will measure lung function and symptom scores in 72 adults over 5 days. The goal is to see if acupuncture offers a new, drug-free option for emergency asthma care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- acupuncture
- What this could lead to
- If it works, this could point toward a drug-free way to quickly relieve asthma attacks.
- What could go wrong
- This is a small, early study with only 72 people. The results may not apply to everyone, and acupuncture's effect could be due to a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 72 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients meeting the Western medicine diagnostic criteria for acute exacerbation of bronchial asthma 2. Aged ≥ 18 years old 3. Voluntarily receive treatment and sign the informed consent form Exclusion Criteria: 1. Those who fail to meet the inclusion criteria 2. Patients suffering from other severe systemic diseases such as diseases of the circulatory system, hematological system and nervous system 3. Pregnant or lactating women 4. Subjects enrolled but not treated per the study protocol 5. Patients who have participated in other clinical trials of medicinal products within 3 months 6. Other circumstances deemed ineligible for enrollment by researchers
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute exacerbation of bronchial asthma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
the First Affiliated Hospital of Henan University of Chinese Medicine
RECRUITINGZhengzhou, Henan, 450000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could vitamin d levels influence asthma control?
- Could a chromium supplement help obese adults breathe easier?
- Golfers test N95 masks to breathe easy in wildfire smoke
- Massive study reveals hidden dangers of common steroid treatments
- Breath prints may reveal lung disease secrets without needles
- Asthma drug roflumilast tested for Long-Term safety in new study